Globus Medical (GMED) Tops Q4 EPS by 2c

Globus Medical (NYSE: GMED) reported Q4 EPS of $0.49, $0.02 better than the analyst estimate of $0.47. Revenue for the quarter came in at $250 million versus the consensus estimate of $243.52 million.

GUIDANCE:

Globus Medical sees FY2022 EPS of $2.10, versus the consensus of $2.26. Globus Medical sees FY2022 revenue of $1.025 billion, versus the consensus of $1.05 billion.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Bernstein SocGen Group Upgrades X-Fab Silicon Foundries SE (XFAB:FP) to Outperform
• Sun Communities names Ileana McAlary as general counsel and EVP